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Objectives: in patients with vascular prosthesis infection, to compare surgical outcome and long-term results of
cryopreserved allograft implantations to conventional surgery.
Design: retrospective study.
Material and Methods: two asynchronous series of 44 [series I: 1980±1994; 8 patients with aortoenteric fistula (AEF)]
and 22 (series II: 1994±1997; 4 patients with AEF) patients were treated for prosthesis infection. All patients had prosthesis
excision. In series I, there were 4 in situ reparations, 26 extra-anatomic bypass, 13 excision only, and one death at
laparotomy. In series II, in situ cryopreserved allografts were implanted in all patients.
Results: operative mortality was 16% in series I and 13.6% in series II. For AEF patients, mortality was 37% in series I
and 50% in series II. Among hospital survivors, infection-related late mortality was 13.5% in series I and 5% in series II.
For AEF patients, late mortality was 20% in series I and 50% in series II. Incidence of reoperations was 54% in series I and
10.5% in series II (p5 0.01). Hospital stay was 47.2+ 26.4 days in series I and 16.6+ 11.5 days in series II (p5 0.001).
Conclusions: compared to conventional treatment, incidence of reoperations and length of hospital stay are significantly
decreased after cryopreserved allograft implantation. However, closure of aortic stump and extra-anatomic bypass gives
better results for patients with AEF.
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Introduction
Regardless of its location (i.e. articular, vascular), any
infected prosthesis must be removed, because such a
foreign body serves as a sanctuary for infectious
pathogens, in which they are protected from anti-
infectious pharmacological agents, and from humoral
and cellular defence mechanisms. In the case of vas-
cular prosthetic infection, excision of the infected
prosthesis is often impossible without an additional
surgical manoeuvre aimed at preserving the arterial
blood flow to the limb previously perfused by the
prosthesis. The conventional surgical approach to
prosthetic vascular infection consists in graft excision
and in some form of extra-anatomic bypass. For sev-
eral authors,1 such conventional surgical treatment
remains the golden standard to which any new form
of treatment for prosthetic vascular infection must be
compared. However, in case of extensive infection,
the complexity of the extra-anatomic reconstruction
required to restore limb perfusion may compromise
its long-term patency. Therefore, in situ implantation
of materials presumed to be more resistant to infec-
tion, such as rifampin-bonded gelatine-sealed textile
graft,2 autologous vein,3±5 or arterial allografts har-
vested from fresh cadavers or from organ donors,
has been investigated. Historically, these allografts
have first been used for aortic root replacement in
the case of extensive aortic valve endocarditis.6 In
1993, Kieffer et al.7 published the first large series of
freshly harvested allografts implanted for in situ
replacement of infected infrarenal aortic prosthetic
grafts. Recently, cryopreserved aortic allografts have
been used in animals.8 Also, as an alternative
approach to extra-anatomic bypass or to in situ allograft
implantations, Darling et al.9 recently proposed retro-
peritoneal in-line aortic bypass with polytetrafluoro-
ethylene grafts. The aim of our study was to assess,
in patients suffering from prosthetic vascular infec-
tion, complicated or not by aortoenteric fistula (AEF),
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surgical outcome and long-term results, after implan-
tations of cryopreserved allografts, as compared to
conventional surgical treatment.
Material and Methods
Population
The study population included all patients who under-
went surgery for prosthetic vascular infection between
1980 and 1997. Series I (1980 to June 1994) consisted of
patients treated with conventional surgery, while cryo-
preserved allografts were implanted in all patients of
series II (July 1994 to 1997). Results were compared
among patients operated in a single institution, in
terms of operative mortality and morbidity, length of
hospital stay, long-term survival, recurrent infection
and subsequent hospitalisation. In addition, all
patients in whom an allograft was implanted were
seen at the follow-up clinic for clinical examination,
dosage of serum C-reactive protein (CRP), white
blood cell (WBC) count, computed tomography (CT)
scanning and technetium WBC scan. Demographic
characteristics of both series are listed in Table 1.
Series I
Among the 44 patients in series I who underwent
conventional surgery between 1980 and 1994, 23 had
their initial operation in our institution, whereas 21
were referred to us after an operation had been
performed elsewhere. At the time of initial treatment
for prosthetic vascular infection, the mean age was
65.1 7.9 years, ranging from 47 to 79 years. There
were 40 men and 4 women. In 8 patients, the initial
presentation of prosthetic infection was an aorto-
digestive fistula, with hematemesis (1 patient), rectal
bleeding or melena (6 patients), or both (1 patient). In
30 patients, prosthetic infection developed after one
surgical procedure, whereas it occurred in 14 patients
after several operations, respectively 2 (6 patients), 3
(3 patients), and 4 or more (5 patients) procedures. At
initial surgery, an intra-abdominal vascular anasto-
mosis was constructed in 25 patients, including 18
aortobifemoral bypasses, three aorto-aortic grafts, one
aortobiiliac bypass, and three iliofemoral bypasses.
Surgery remained extra-abdominal in 19 patients,
including three axillofemoral bypasses and 16 femoro-
popliteal bypasses or femoral reconstructions. Among
the group of 30 patients with a history of only 1 vas-
cular surgical procedure, infection developed early
(within less than 3 months) in 13 patients (43%), and
late (after more than 3 months) in 17 (57%). In con-
trast, there were 10 (71%) early and 4 (29%) late infec-
tions among the 14 patients who had two or more
vascular operations.
Infection was due to a variety of organisms (Table 2):
Gram-positive cocci, including Staphylococcus epider-
midis (11 patients), Staphylococcus aureus (8 patients),
Streptococcus faecalis (5 patients); Gram-positive
bacilli such as Corynebacterium (3 patients); several
Gram-negative bacteria (28 patients); Candida albicans
(4 patients). One patient had methicillin-resistant
Staphylococcus aureus (MRSA) infection. Multiple orga-
nisms grew in 19 patients, a single organism in 14,
whereas no organisms were cultured in 7 patients.
Bacteriological data were missing in 4 records.
Table 1. Patient preoperative characteristics.
Variables Series I Series II Comparison
n 44 n 22 p value
number (%) number (%)
Demographics
Gender (men/women) 40/4 20/2 NS
Mean age
(mean SD, years)
65.1 7.9 62.4 8.6 NS
Initial surgery
Performed elsewhere 21 (48) 13 (59) NS
In our institution 23 (52) 9 (41) NS
Previous vascular procedure
Number
One operation 30 (68) 7 (32) 50.01
 2 operations 14 (32) 15 (68) 50.05
Location
Intra-abdominal 25 (57) 18 (82)
Aorta 22 12
Iliac artery 3 6
Extra-abdominal 19 (43) 4 (18)
Prosthetic infection
Early (53 months) 23 (52) 12 (55) NS
One operation 13 1
2 operations 10 11
Delayed (43 months) 21 (48) 10 (45)
One operation 17 6
2 operations 4 4
Table 2. Bacteriological data.
Organisms Series I Series II Comparison
n 40 n 22 p value
number (%) number (%)
Gram-positive bacteria 24 (60) 17 (77) NS
Staphylococcus epidermidis 11 (28) 2 (9) NS
Staphylococcus aureus 8 (20) 13 (59) 5 0.002
Streptococcus faecalis 5 (12) 2 (9) NS
Corynebacterium 3 (7) 0 NS
Gram-negative bacteria 28 (70) 14 (64) NS
Candida albicans 4 (10) 3 (14) NS
Multiple pathogens 19 ( 48) 8 (36) NS
Single pathogens 14 (35) 11 (50) NS
No pathogen cultured 7 (17) 3 (14) NS
Bacteriological data were missing in 4 patientsGram-negative bacteria included enterococcus, Serratia marcescens,
Enterobacter cloacae, Enterococcus faecalis, Escherichia coli etc.
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Pathogens that were cultured from patients with
AEF included Enterococcus faecalis (3 patients) or cloacae
(2 patients), Candida albicans (2 patients), Serratia mar-
cescens (1 patient), Pseudomonas aeruginosa (1 patient),
Corynebacterium (1 patient), Klebsiella pneumoniae
(1 patient). Four organisms grew in 1 patient, 2 in 2
patients, and a single pathogen grew in 4 patients. No
organism grew in 1 patient with AEF.
Antibiotics were given in accordance with the sen-
sitivity of the germ. Without this information, vanco-
mycin 1 g/12 h and gentamycin 1 mg/kg/8 h were
given intravenously.
Series II
Between 1994 and July 1997, a cryopreserved allograft
was implanted in situ after excision of the infected
prosthesis in 22 patients. Among those, 4 patients
had developed an aortoenteric fistula. As shown in
Table 1, 9 patients had surgery in our institution, and
13 were referred from other hospitals. There were 20
males and 2 females. The mean age was 62.4 8.6
years, ranging from 48 to 76 years. In 7 patients, pros-
thetic infection developed after 1 surgical procedure,
but after several vascular operations in 15, respectively
after 2 (3 patients), 3 (5 patients), and 4 or more (7
patients) procedures. Indication for initial surgery
was abdominal aortic aneurysm in 7 patients (4 aorto-
bifemoral bypasses, 1 aortobiiliac bypass, and
2 aorto-aortic grafts), aortoiliac occlusive disease in
11 (5 aortobifemoral bypasses and 6 iliofemoral grafts),
and peripheral arteriopathy in 4 (3 femoropopliteal
bypasses and one femorofemoral graft). In total, prox-
imal prosthetic anastomoses were intra-abdominal in
18 patients (12 aortic and 6 iliac), and extra-abdominal
in 4. Among the group of 7 patients with a history of
only 1 vascular surgical procedure, infection devel-
oped early in 1 patient (14%), and late in 6 (86%). In
contrast, there were 11 (73%) early and 4 (27%) late
infections among the 15 patients who had 2 or more
vascular operations (Table 1).
Infection was due to multiple microorganisms in 8
patients, to a single pathogen in 11, whereas no patho-
gens were cultured in 3 patients. Gram-positive cocci
grew in 17 patients (Staphylococcus aureus in 13,
Staphylococcus epidermidis in 2, and Streptococcus pyo-
genes in 2), Gram-negative bacilli in 14, and Candida
albicans in 3 (Table 2). Ten patients had MRSA
infection.
Among the 4 patients with AEF, pathogens included
Candida albicans (3 patients), MRSA (3 patients),
Escherichia coli (2 patients), Acinetobacter (1 patient),
Enterobacter cloacae (1 patient), and Morganella morganii
(1 patient). Four pathogens grew in 1 patient, 3 in
1 patient, and 2 in 2 patients.
As in series I, antibiotics were given in accordance
with the sensitivity of the germ. Without this informa-
tion, vancomycin 1 g/12 h and gentamycin 1 mg/kg/
8 h were given intravenously. In addition, rifampicine
300 mg/12 h was given orally. This was the only dif-
ference in antibiotics policy between the two groups.
Procurement and preservation of allografts
All arterial allografts were supplied by a European
Center, which collects the arteries harvested from
organ donors or from fresh cadavers. Bacteriology
and virology tests were routinely performed for
donors. After harvesting, the grafts were examined
by angioscopy in a sterile medium under laminar
flow, in order to eliminate arteries with suspect
lesions. Decontamination was obtained by a 48 h
immersion in a multi-antibiotic solution. Finally, the
arteries were frozen in a solution containing a 10%
concentration cryoprotective agent ± dimethylsulfoxide
± and stored at ÿ150 or ÿ180C in the vapour phase
of a liquid nitrogen freezer. The freezing rate was
controlled in order to prevent the development of
intracellular ice crystals, the freezing process lasting
less than 30 min. After the implanting surgeon had
ordered the appropriate graft, it was supplied in a
liquid nitrogen tanker. Unlike the freezing process,
thawing was always rapid. The allograft was thawed
in a water bath at 42 C and then rinsed in successive
baths of saline solution containing decreasing concen-
trations of dimethylsulfoxide. Care was always taken
not to handle the frozen allograft clumsily, in order to
prevent transverse fractures that may cause immedi-
ate or delayed problems. Before implantation, an
allograft fragment was collected for subsequent
bacteriological culture.10
Statistical analysis
Results are expressed as mean SD for quantitative
variables and as counts and proportions for categorical
findings. Mean values observed in the two series before
the operation were compared by means of the classical
Student t-test and proportions by the chi-squared test.
To compare the two series postoperatively, the odds
ratio (OR) and associated 95% confidence interval
were calculated for each outcome. Results were
considered to be significant at the 5% critical level
(p5 0.05).
EHB (European Homograft Bank), Military Hospital, Bruynstraat,
1128, Brussels, Belgium.
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Results
Series I
Early results
Surgical treatment of vascular infection included exci-
sion of the prosthesis in all 44 cases. In 13 patients,
there was no additional procedure. Vascular recon-
struction was performed with an aortobifemoral
textile graft implanted in situ in 2 patients; both of
them presented with an aortoenteric fistula and died
postoperatively. Two patients had a saphenous vein
femoropopliteal bypass. An extra-abdominal textile
bypass was constructed in 26 patients, including 12
axillofemoral, 4 axillopopliteal, nine transobturator,
and 1 femorofemoral bypasses (Table 3). One patient
who had developed an aortoenteric fistula died at
laparotomy, without further vascular procedure. In
this series, an omentoplasty was performed in 1
patient, as biological coverage after excision of the
infected prosthesis.
Operative mortality (Table 4) was 16% (7 patients).
Among the group of 36 patients without an aortoen-
teric fistula, mortality was 11% (4 patients). There were
2 cardiac deaths and 2 deaths secondary to pulmonary
complications. In contrast, mortality was 37.5%
(3 patients) among the group of 8 patients who pre-
sented with an aortoenteric fistula. One patient died at
laparotomy, and 2 patients died from recurrent infec-
tion after a rifampin-bonded textile graft had been
implanted, respectively, on the tenth and twenty-first
postoperative days. The remaining 5 patients in whom
an extra-abdominal bypass was implanted after clos-
ure of the aortic stump survived after surgery and
were discharged from hospital.
Late results
Thirty-seven patients were discharged from hospital.
Among hospital survivors, 9 deaths occurred during
the 14-year period. Infection-related late mortality was
12.5% (4 patients) among the 32 patients without fistula
and was 20% (1 patient) among the 5 patients with
aortoenteric fistula: this patient died 4 years after aortic
stump closure and extra-anatomic bypass, from recur-
rent infection and aortoenteric fistula. In addition, there
were 4 non-infection-related late deaths: 2 patients died
from cerebrovascular accidents, one from myocardial
infarction, and one from unknown origin (Table 4).
At least one additional surgical procedure was per-
formed in 20 patients (54%), either after extra-
anatomic vascular reconstruction (19 patients), or after
prosthesis excision (1 patient) (Table 5). Indications for
additional surgical interventions included mid-thigh
amputation in 4 patients (bilateral amputation in one)
and recurrent vascular infection in 8. One patient
has intractable ischaemic contracture secondary to
compartmental syndrome. Among the 4 patients who
required thigh amputation, 3 had a revascularisation
procedure that later failed, and 1 was in the resection-
only subgroup. Excluding deaths during initial hospi-
talisation, mean cumulative hospital stay was
47.2 26.4 days, ranging from 15 to 130 days.
Series II
Early results
In this series, all 22 patients had a cryopreserved allo-
graft implanted to treat prosthetic infection. Proximal
Table 3. Vascular reconstruction after excision of infected
prosthesis.
Procedures Series I Series II
n 44 n 22
number number
In situ repair
With intra-abdominal textile graft 2 0
With extra-abdominal saphenous vein 2 0
With cryopreserved allograft 0 22
Extra-anatomic bypass 26 0
Axillofemoral 12 0
Axillopopliteal 4 0
Transobturator 9
Femorofemoral 1
No vascular reconstruction 13 0
Laparotomy-intraoperative death 1 0
Excision of infected prosthesis was performed in all patients.Patient included on the `` intention to treat'' principle.
Table 4. Operative and late mortality.
Series I Series II Odds ratio
n 44 n 22 (95% CI)
number (%) number (%)
Operative mortality 7 (16) 3 (14) 1.20 (0.28±5.20)
Patients with AEF 3 2
Patients without AEF 4 1
Late mortality 9 (24) 2 (10.5) 2.73 (0.52±14)
Infection-related 5 (14) 1 (5) 2.81 (0.30±26)
Patients with AEF 1 1
Patients without AEF 4 0
Non infection-related 4 (11) 1 (5) 2.18 (0.61±21)
Cerebrovascular
accident
2 0
Acute myocardial
infarction
1 0
Lung carcinoma 0 1
Unknown origin 1 0
Total mortality 16 (32) 5 (23)
AEF aortoenteric fistula.All late mortality percentages are expressed among hospital
survivors.
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allograft anastomoses were intra-abdominal in 19
patients, whereas 3 patients had femoropopliteal allo-
graft bypasses. Intra-abdominal procedures included 8
iliofemoral, 5 aortofemoral, and 2 aortoiliac bypasses,
2 aorto-aortic grafts, and 2 aortofemoral grafts
with additional femoropopliteal bypasses. Whenever
technically possible, the allograft was covered by
omentoplasty.
Operative mortality (Table 4) was 13.6% (3 patients).
Causes of death were massive haemorrhage in 2
patients (after aortobiiliac allograft bypass for aorto-
enteric fistula), respectively, at postoperative days
9 and 22, and myocardial infarction in 1 patient at
postoperative day 4. Operative mortality was 50%
(2 patients) in the subgroup of patients with aortoenteric
fistula, but was 5.5% (1 patient) in patients without
such a fistula. Two patients developed non-lethal
early postoperative complications, including 1 recur-
rent aortoenteric fistula treated with allograft resec-
tion, closure of aortic stump, and axillofemoral bypass,
and 1 lower extremity ischaemia requiring extension
of the femoral anastomosis.
Late results
Nineteen patients were discharged from hospital.
Infection-related late mortality was 5%: 1 patient
with an allograft implanted for aortoenteric fistula
died 8 months after surgery, secondary to rupture of
the proximal anastomosis (Table 4). It should be
emphasised that all 4 patients who presented with
an aortoenteric fistula later developed a rupture of
the allograft proximal anastomosis. Three of them
died, either in the early postoperative period or dur-
ing follow-up, and the fourth patient only survives
after extra-anatomic bypass grafting. There was 1
non-infection-related late death, from lung carcinoma.
Long-term survival was compared between the 2
groups, with the comparison limited to the first 5 post-
operative years as it was the longest follow-up avail-
able for patients in series II, and was similar (Fig. 1).
Infection-related late morbidity included 1 mid-
thigh amputation, because of late thrombosis of the
femoropopliteal bypass and severe distal arteriopathy,
and 1 pseudo-aneurysmal anastomotic leakage treated
with a second allograft implantation. Incidence of
reoperation was 14% (3 patients). Mean cumulative
hospital stay for all surgical procedures was
16.6 11.5 days, ranging from 10 to 61 days (Table 5).
Among the 19 hospital survivors, 16 patients were
seen at the follow-up clinic. Mean follow-up was 18
months (extremes: 12±60 months) after allograft
implantation. Follow-up included clinical examina-
tion, serum CRP dosage, WBC count, CT scanning,
and technetium WBC scan. No patient had leucocy-
tosis. Three patients had moderately elevated CRP
values, respectively 29, 26 and 20 mg/L (normal
values: 0±6 mg/L). No abnormal allograft fixation
was observed at technetium WBC scan. At CT scan-
ning, an inguinal collection was detected in 2 patients,
without clinical sign of infection or pseudoaneurys-
mal degeneration. All explanted cryopreserved allo-
grafts were submitted to careful histological analysis,
and no cracking or other injuries were observed.
Discussion
Although the patients treated most recently undoubt-
edly benefited from better intensive care and more
effective antibiotics than those available in the early
1980s, the operative techniques performed by the
same surgical team for both series remained
Table 5. Late morbidity among hospital survivors.
Events Series I Series II Odds ratio
n 37 n 19 (95% CI)
number (%) number (%)
Reoperation 20 (54) 2 (10.5) 10 (2±49)
After extraanatomic
bypass
19
Axillofemoral 7
Axillopopliteal 4
Transobturator 7
Femorofemoral 1
After straightforward
excision
1
Amputation 4 (11) 1 (5) 2.18 (0.23±21)
Disabling ischaemic
contracture
1 (3) 0 na
Recurrent infection 8 (22) 1 (5) 4.97 (0.57±43)
Hospital stay
(mean sd, days)
47.2 26.4 16.6 11.5 50.001
Bilateral amputation in 1 patient.
Fig. 1. Five-year survival for all patients, including hospital deaths.
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unchanged. For some authors,11 however, comparison
between 2 different treatments should be limited to
the results obtained during the decade immediately
preceding change in surgical technique. One major
change over the years, however, has been the avail-
ability of CT scans and labelled leucocyte scans. In our
experience, this significant improvement in diagnostic
imaging contributed to earlier diagnosis, at least for
the patients treated and followed in our institution.
Therefore, our results must be interpreted bearing in
mind the specific features of each series.
Both series are comparable in terms of age, sex and
proportion of aortoenteric fistula. There are more
patients referred from other hospitals in series II
(59%) than in series I (48%), but the difference is not
statistically significant. The proportions of early and
delayed infections are also similar in both series. On
the other hand, incidence of infection after 1 surgical
procedure is higher in series I (68%) than in series II
(32%) (p5 0.01), and more patients had an intra-
abdominal anastomosis in series II (82%) than in series
I (57%) (p5 0.05). The significantly higher proportion
of extra-abdominal anastomoses (43%) in series I
explains why in some patients no vascular reconstruc-
tion was performed after excision of the infected
material. The significantly higher incidence
(p5 0.002) of S. aureus that we observed in series II
(the most recent), as compared with series I, is in
opposition with most literature reports: S. aureus was
responsible for most prosthetic infections 20 years ago,
but has now been replaced by S. epidermidis.12
It should be emphasised that the historical bias
which affects the comparison of these 2 series has
certainly not been in favour of series II, characterised
by a higher incidence of more aggressive pathogens,
including MRSA (Table 2) and of intra-abdominal
prosthesis. Whereas infection of inguinal prosthesis
can usually be treated by simple excision, prosthetic
intra-abdominal infections represent a much more dif-
ficult surgical challenge. By definition, all patients in
series II underwent excision of the infected prosthesis
and in situ allograft implantation, whereas different
surgical therapies were used for patients in series I.
For example, patients with extra-abdominal prosthesis
underwent simple prosthetic excision, without further
vascular reconstruction.
Results of any form of treatment for prosthetic vas-
cular infection can never be considered as definitive.
For example, one of our patients initially presenting
with an aortoenteric fistula and successfully treated
with prosthesis excision and axillobifemoral bypass
developed, 4 years after apparent cure, recurrent aorto-
enteric fistula and died after emergent surgery. At
that time, labelled WBC scans were not routinely
performed. In contrast, technetium WBC scans were
performed several months after cryopreserved allo-
graft implantation in 16 patients and have all been
negative. This has now become a routine procedure
in our institution.
Operative mortality was 16% for patients treated
with conventional surgery, and was 14% after allograft
implantations (NS). Total (operative and late) infection-
related mortality was 27% for series I, and was 18%
for series II (NS). Length of follow-up is obviously
different for each series.
For patients who presented with an aortoenteric
fistula, operative mortality was 50% after conventional
surgical treatment (0% after closure of the aortic
stump and extra-anatomic vascular reconstruction),
and was 75% after allograft implantation. For these
patients treated with prosthesis excision and allograft
implantation, technical failure was 100%: 3 patients
died and 1 patient developed a rupture of the prox-
imal allograft anastomosis and was finally success-
fully treated by conventional surgery.
Incidence of reoperation was higher after conven-
tional treatment (45%) than after allograft implanta-
tion (10.5%) (p5 0.01). Also, reoperations were more
frequent after extra-anatomic bypass (73%) than after
prosthetic excision without further reconstruction
(8%). Total incidence of amputation was 9% after con-
ventional surgery (or 11% among hospital survivors),
and was 5% (1 patient) after allograft implantation.
In addition, 1 patient in series I is severely impotent
because of intractable ischaemic contracture. Among
37 hospital survivors after conventional surgery, infec-
tion recurred in 8 patients (22%), and in 1 among
19 patients (5%) that had received an allograft (NS).
For hospital survivors, the mean cumulative hospital
stay was 47.2 days in series I and 16.6 days in series II
(p5 0.001). After prosthesis resection and extra-
anatomic bypass, other authors reported an operative
mortality of 15, 18 and 26%,11,13,14 respectively, and
an incidence of amputation of 5, 9 and 21%,11,13,14
respectively.
In our series of allograft implantations, there was 1
late amputation and 2 reoperations. One patient who
had an aortoenteric fistula was reoperated early for
proximal anastomotic rupture; this could be consi-
dered as infectious recurrence, despite negative bac-
teriologic cultures (Table 5). The other reoperation was
indicated to correct an anastomotic pseudoane-
urysmal degeneration. After allograft implantation,
other authors reported an operative mortality of
18±25%,15,16 which compares favourably with our
series, and amputation rates of 2.9±3.5%.15,16
Surgical outcome of the 12 patients who presented
with an aortoenteric fistula needs to be analysed in
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detail. Among 8 patients treated conventionally,
3 died in the early postoperative period and 1 patient
died 4 years later of recurrent aortoenteric fistula. This
is an operative mortality of 37.5% and a total mortality
of 50%. Among 4 patients treated with in situ allograft
implantation, 2 died postoperatively and 1 patient
developed rupture of the proximal anastomosis at
postoperative day 8, and was treated with allograft
excision, closure of the aortic stump, and axillo-
femoral bypass. The only patient discharged from hos-
pital with an allograft implanted for aortoenteric
fistula died eight months later, secondary to rupture
of the proximal allograft anastomosis. This is a 75%
overall mortality and a 100% technical failure. In a
larger series of allograft implantation, with an inci-
dence of aortoenteric fistula of 39%, operative mortal-
ity was 37%.16 These results are better than our short
experience with allograft implantation in patients
with aortoenteric fistula, but substantially worse
than our results with prosthesis excision and extra-
anatomic vascular reconstruction. It should also be
noted that in the experience of Bahnini et al.,16
implanted allografts were freshly harvested, not cryo-
preserved. In a multicentric study carried out by the
users of allografts cryopreserved by the EHB, mortal-
ity was 83% for patients with an aortoenteric fistula
(65% early and 18% late mortality, respectively).17 The
first reports of early rupture and degeneration of cryo-
preserved allografts were published by Lehalle et al.18
According to England et al.,19 the incidence of recur-
rent aortoenteric fistula varies from 25% to 100% after
in situ reconstructions, and from 17% to 50% after aortic
stump closure and extra-anatomic reconstruction.
As an alternative to conventional treatment or to
allograft replacement, Nevelsteen et al.4 and Clagett
et al.5 have reported their experience with the use
of superficial femoro-popliteal veins for aorto-
ilio-femoral reconstructions after excision of infected
prosthesis. In these series, as in our experience, mor-
tality is influenced by the initial clinical presentation.
For example, Nevelsteen et al.4 reported an 11% mor-
tality in patients with isolated prosthetic infection, but
a 37.5% mortality in patients with AEF. However, it
should be emphasised that, in this series, no patient
died because of a rupture of the autogenous vein.
Considering that our poor results after cryopre-
served allograft implantation for aortoenteric fistula
are also those reported by other surgeons using such
allografts from the EHB,17 the question arises whether
the diminished resistance to infection could be due to
allograft preparation techniques. Selection and prep-
aration criteria of allografts by the EHB, discussed
elsewhere,10 are extremely selective. However, the
pathologist in charge at the EHB insists that clumsy
handling during the thawing process could trigger
lesions of the extracellular arterial matrix, which
could be responsible for later ruptures. Lehalle et al.18
recently reported numerous cases of cryopreserved
allograft rupture. These authors18 questioned the
basic principle of cryopreservation, introduced to
extend allograft availability and to suppress possible
viral contamination from fresh allografts. However,
for patients without aortoenteric fistula, cryopre-
served allografts are very resistant; rupture of the
proximal allograft±aortic anastomosis has not been
reported. Several authors20,21 insist on the importance
of complete excision at the infected proximal anasto-
mosis. Was our surgical excision too limited? In each
patient, all textile and suture materials were removed,
and the extent of excision was only limited by the
proximity of the renal arteries.
Since we cannot determine the cause of rupture
after allograft implantation for aortoenteric fistula,
we have decided not to use allografts for such
patients, but to treat them with conventional excision
and extra-anatomic reconstruction. Should the fem-
oral sites be infected, thus compromising the distal
implantation of a textile axillofemoral bypass, we use
an axillofemoral allograft. We also frequently use a
composite graft, textile in the upper three quarters,
and allograft in the lower quarter, for suture to
the infected femoral artery, while sparing allograft
length.
Having made these warnings on allograft use in
patients with aortoenteric fistula, we must duly
acknowledge the feasibility and simplicity of cryopre-
served allograft implantation, and the good results
observed, at least at early and mid-term follow-up.
Cryopreservation allows for the creation of an organ
bank, suppresses possible viral contamination, and
destroys arterial surface antigenicity.22 The low inci-
dence of reoperations, compared with conventional
surgical techniques, is due to the orthotopic character
of arterial repair, which is a decisive factor in main-
taining reconstruction long-term permeability. This
also explains the lower morbidity, in terms of reopera-
tions or extended hospital stay, as compared to con-
ventional surgical treatment.
Two remarks are important, however, in order to
soften our conclusions. First, this series, homogeneous
in terms of surgical team, is relatively small, which
makes statistical conclusions difficult. In particular,
the number of aortoenteric fistula is small in each
group and this could impair the validity of our con-
clusions. Second, the important question of delayed
infection recurrence remains. Without a satisfactory
answer to this question, no one can pretend to have
achieved definitive cure of the infection, whatever the
422 J.-P. Lavigne et al.
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method employed. However, to date all labelled WBC
scans have been negative, which is encouraging.
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